Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04728854 · ClinicalTrials.gov registry record
Telederm and Bullous Pemphigoid
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 21
- Enrollment target
NCT04728854 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 21 participants.
The verdict
NCT04728854 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The purpose of the study is to improve the quality of future clinical trials in bullous pemphigoid (BP), the investigators will monitor repeated measurement data from patients with BP on standard-of-care treatments at four week intervals for four months.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2021-03-15 |
| Est. Completion | 2023-10-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04728854
The ClinicalTrials.gov registry entry for NCT04728854 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04728854 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04728854 about?
NCT04728854 is a clinical study titled "Telederm and Bullous Pemphigoid". The purpose of the study is to improve the quality of future clinical trials in bullous pemphigoid (BP), the investigators will monitor repeated measurement data from patients with BP on standard-of-care treatments at four week intervals for four months.
What is the current status of trial NCT04728854?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2021-03-15. Estimated completion is 2023-10-06.
Who is sponsoring clinical trial NCT04728854?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.